
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product c... Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004). Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.03 | -0.587084148728 | 5.11 | 5.5295 | 5 | 1152739 | 5.2436121 | CS |
4 | -1.63 | -24.2921013413 | 6.71 | 7.585 | 4.32 | 2196016 | 5.12212397 | CS |
12 | -7.64 | -60.0628930818 | 12.72 | 13.71 | 4.32 | 1470902 | 7.03896187 | CS |
26 | -8.42 | -62.3703703704 | 13.5 | 17.66 | 4.32 | 960254 | 9.03545406 | CS |
52 | -16.32 | -76.261682243 | 21.4 | 25.42 | 4.32 | 713742 | 12.41339272 | CS |
156 | -18.35 | -78.3183952198 | 23.43 | 79.65 | 4.32 | 627420 | 32.3328449 | CS |
260 | -4.45 | -46.6946484785 | 9.53 | 79.749 | 4.32 | 529526 | 32.63585995 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales